Rhizen Pharmaceuticals SA   Report issue

For profit Phase 1 Phase 2
Founded: La Chaux-de-Fonds Switzerland (2008)

Organization Overview

First Clinical Trial
2013
NCT02017613
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Rhizen Pharmaceuticals SA